Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
ACCENDRA HEALTH INC/VA/ reported six months ended June 30, 2023 results: revenue $5,086, net income $(52.7), EPS $(0.70).
- Period
- six months ended June 30, 2023
- Revenue
- $5,086
- Net income
- $(52.7)
- EPS
- $(0.70)
- Result
- reported results
Exact text from the filing
Financial Summary (1) YTD YTD ($ in millions, except per share data) 2Q23 2Q22 2023 2022 Revenue $2,563 $2,500 $5,086 $4,907 Operating income, GAAP $10.8 $75.1 $20.6 $136.1 Adj. Operating Income, Non-GAAP $62.0 $113.6 $109.7 $218.5 Net (loss) income, GAAP $(28.2) $28.6 $(52.7) $67.9 Adj. Net Income, Non-GAAP $14.2 $58.3 $17.8 $131.0 Adj. EBITDA, Non-GAAP $112.8 $163.4 $221.5 $285.9 Net (loss) income per common share, GAAP $(0.37) $0.37 $(0.70) $0.89 Adj. Net Income per share, Non-GAAP $0.18 $0.76 $0.23 $1.72
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
ACCENDRA HEALTH INC/VA/ reported second quarter ended June 30, 2023 results: revenue $2.56 billion, net income $(0.37) per common share, EPS $(0.37) per common share.
- Period
- second quarter ended June 30, 2023
- Revenue
- $2.56 billion
- Net income
- $(0.37) per common share
- EPS
- $(0.37) per common share
- Result
- reported results
Exact text from the filing
Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the second quarter ended June 30, 2023. Second Quarter Key Highlights: • Consolidated revenue of $2.56 billion • Net loss per common share of $(0.37) and adjusted net income per common share of $0.18
View on SEC.gov